Activity of liver fructose diphosphatase from chick embryos treated with aminoguanidine sulfate

Area of Science:

• Biochemistry
• Developmental Biology
• Enzymology

Background:

• Fructose diphosphatase (FDPase) is a key gluconeogenic enzyme.
• Enzyme activity regulation is crucial for metabolic control during development.

Purpose of the Study:

• To investigate the effect of aminoguanidine sulfate (AGS) on chick embryo liver FDPase activity.
• To determine the mechanism behind any observed changes in FDPase specific activity.

Main Methods:

• Chick embryos were injected with aminoguanidine sulfate (AGS) on day 4 of incubation.
• Liver FDPase specific activity was measured prior to hatching.
• Levels of potential enzyme inhibitors, such as adenosine 5'-monophosphate (AMP), were assessed.

Main Results:

• AGS injection led to a significant decrease in liver FDPase specific activity.
• The reduced FDPase activity correlated with increased levels of adenosine 5'-monophosphate (AMP).
• Evidence suggested that AMP acted as an inhibitor, rather than a direct repression of FDPase synthesis.

Conclusions:

• Aminoguanidine sulfate (AGS) negatively impacts liver FDPase activity in developing chick embryos.
• The primary mechanism involves inhibition by elevated adenosine 5'-monophosphate (AMP) levels.
• This finding highlights the sensitivity of metabolic enzyme regulation during embryonic development.